CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions in Viral Infection and Prevention
暂无分享,去创建一个
Mengji Lu | Qinxue Hu | Kai Hu | Lihua Huang | Yan Yan | Xu Wang | Renfang Chen
[1] T-Cell Chemokine , 2020, Definitions.
[2] S. Zibaee,et al. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice. , 2019, Microbial pathogenesis.
[3] D. Legler,et al. CCR7 Is Recruited to the Immunological Synapse, Acts as Co-stimulatory Molecule and Drives LFA-1 Clustering for Efficient T Cell Adhesion Through ZAP70 , 2019, Front. Immunol..
[4] J. Fernandes,et al. Monocytes of patients with unstable angina express high levels of chemokine and pattern‐recognition receptors , 2019, Cytokine.
[5] W. Zhiming,et al. Chemokines and receptors in intestinal B lymphocytes , 2018, Journal of leukocyte biology.
[6] D. Tscharke,et al. Tissue‐resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance , 2018, Immunological reviews.
[7] Yong-Sun Kim,et al. Prolonged follicular helper T cell responses in ME7 scrapie-infected mice , 2018, Prion.
[8] F. Rezaei,et al. The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus. , 2018, Viral immunology.
[9] Jia Liu,et al. TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production , 2018, The Journal of Immunology.
[10] S. H. van der Burg,et al. Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections , 2018, Front. Immunol..
[11] H. Wille,et al. Somatostatin in Alzheimer's disease: A new Role for an Old Player , 2018, Prion.
[12] I. Ernberg,et al. Epstein–Barr virus (EBV) provides survival factors to EBV+ diffuse large B‐cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL , 2017, Immunology.
[13] D. Zawieja,et al. A Novel Computational Model Predicts Key Regulators of Chemokine Gradient Formation in Lymph Nodes and Site-Specific Roles for CCL19 and ACKR4 , 2017, The Journal of Immunology.
[14] P. Djurdjevic,et al. Cytokine profile in chronic hepatitis C: An observation , 2017, Cytokine.
[15] J. Sidney,et al. Bolstering the Number and Function of HSV-1–Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease , 2017, The Journal of Immunology.
[16] J. E. Lima,et al. Multiple Myeloma Cells Express Key Immunoregulatory Cytokines and Modulate the Monocyte Migratory Response , 2017, Front. Med..
[17] D. Montefiori,et al. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques , 2017, Journal of Virology.
[18] Angela M. Jarrett,et al. CCR7 Modulates the Generation of Thymic Regulatory T Cells by Altering the Composition of the Thymic Dendritic Cell Compartment. , 2017, Cell reports.
[19] R. Thimme,et al. Overcoming CD8+ T-Cell Exhaustion in Viral Hepatitis: Lessons from the Mouse Model and Clinical Perspectives , 2017, Digestive Diseases.
[20] S. Lira,et al. Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis , 2017, Journal of Virology.
[21] S. Self,et al. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Prima , 2017, Journal of Virology.
[22] M. Ferracin,et al. Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B , 2017, Nature Medicine.
[23] B. '. ’t Hart,et al. Analysis of the cross-talk of Epstein–Barr virus-infected B cells with T cells in the marmoset , 2017, Clinical & translational immunology.
[24] A. Spivak,et al. Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo , 2016, Retrovirology.
[25] M. Rosenkilde,et al. Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines , 2016, Front. Immunol..
[26] Ah Ram Lee,et al. Hepatitis B virus–triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response , 2016, Autophagy.
[27] A. Uusküla,et al. T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. , 2016, Viral immunology.
[28] S. H. van der Burg,et al. The Breadth of Synthetic Long Peptide Vaccine-Induced CD8+ T Cell Responses Determines the Efficacy against Mouse Cytomegalovirus Infection , 2016, PLoS pathogens.
[29] Yong-Sun Kim,et al. Impaired spleen structure and chemokine expression in ME7 scrapie-infected mice. , 2016, Immunobiology.
[30] M. Churchill,et al. HIV integration and the establishment of latency in CCL19-treated resting CD4+ T cells require activation of NF-κB , 2016, Retrovirology.
[31] S. Lewin,et al. Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro , 2016, PloS one.
[32] U. Holzgrabe,et al. Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor* , 2016, The Journal of Biological Chemistry.
[33] D. Legler,et al. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes , 2016, Journal of leukocyte biology.
[34] R. Solari,et al. Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery? , 2016, Journal of leukocyte biology.
[35] R. Thimme,et al. CD8+ T-Cell Responses in Hepatitis B and C: The (HLA-) A, B, and C of Hepatitis B and C , 2016, Digestive Diseases.
[36] G. Tiegs,et al. Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells , 2016, Cellular & Molecular Immunology.
[37] Rajesh Raju,et al. Differential ligand-signaling network of CCL19/CCL21-CCR7 system , 2015, Database J. Biol. Databases Curation.
[38] R. Shattock,et al. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9. , 2015, The Journal of general virology.
[39] Qinxue Hu,et al. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge , 2015, The Journal of Immunology.
[40] Ling-Jun Ho,et al. Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus , 2015, Journal of cellular and molecular medicine.
[41] T. Shioda,et al. The HIV-1 Gp120/CXCR4 Axis Promotes CCR7 Ligand-Dependent CD4 T Cell Migration: CCR7 Homo- and CCR7/CXCR4 Hetero-Oligomer Formation as a Possible Mechanism for Up-Regulation of Functional CCR7 , 2015, PloS one.
[42] D. Montefiori,et al. DNA Vaccine Molecular Adjuvants SP-D-BAFF and SP-D-APRIL Enhance Anti-gp120 Immune Response and Increase HIV-1 Neutralizing Antibody Titers , 2015, Journal of Virology.
[43] W. Cao,et al. CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[44] V. Planelles,et al. Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells. , 2014, Cell reports.
[45] M. Rosenkilde,et al. Biased and G Protein-Independent Signaling of Chemokine Receptors , 2014, Front. Immunol..
[46] Anthony R Cillo,et al. Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy , 2014, Proceedings of the National Academy of Sciences.
[47] A. Luster,et al. Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.
[48] Y. Jang,et al. Enhancement of Immune Responses by Co-delivery of CCL19/MIP-3beta Chemokine Plasmid With HCV Core DNA/Protein Immunization , 2014, Hepatitis monthly.
[49] D. van Baarle,et al. T Cell Responses to Viral Infections – Opportunities for Peptide Vaccination , 2014, Front. Immunol..
[50] Wei Zhang,et al. HSV-2 Vaccine: Current Status and Insight into Factors for Developing an Efficient Vaccine , 2014, Viruses.
[51] B. Nakstad,et al. Downregulation of IL7R, CCR7, and TLR4 in the cord blood of children with respiratory syncytial virus disease. , 2013, The Journal of infectious diseases.
[52] J. Schwarze,et al. Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of Respiratory Syncytial Virus infection , 2018, Cytokine.
[53] R. Shattock,et al. CCL19 and CCL28 Augment Mucosal and Systemic Immune Responses to HIV-1 gp140 by Mobilizing Responsive Immunocytes into Secondary Lymph Nodes and Mucosal Tissue , 2013, The Journal of Immunology.
[54] S. McColl,et al. A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system. , 2013, Cytokine & growth factor reviews.
[55] Thomas Gebhardt,et al. Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.
[56] J. Slupsky,et al. Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF , 2012, Thorax.
[57] Nupur Bhatnagar,et al. Loss of CCR7 Expression on CD56bright NK Cells Is Associated with a CD56dimCD16+ NK Cell-Like Phenotype and Correlates with HIV Viral Load , 2012, PloS one.
[58] S. Frøland,et al. Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS) , 2012, Clinical and experimental immunology.
[59] R. Kornbluth,et al. Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine. , 2012, Vaccine.
[60] D. Chang,et al. Immunosuppressive Effects and Mechanisms of Leflunomide in Dengue Virus Infection of Human Dendritic Cells , 2011, Journal of Clinical Immunology.
[61] R. Rabin,et al. Low CCR7-Mediated Migration of Human Monocyte Derived Dendritic Cells in Response to Human Respiratory Syncytial Virus and Human Metapneumovirus , 2011, PLoS pathogens.
[62] A. Osterhaus,et al. Reciprocal changes of naïve and effector/memory CD8+ T lymphocytes in chronic hepatitis B virus infection. , 2011, Viral immunology.
[63] Yuriko Tanaka,et al. Altered antibody production and helper T cell function in mice lacking chemokines CCL19 and CCL21‐Ser , 2010, Microbiology and immunology.
[64] Percy A. Knolle,et al. Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.
[65] Suha M. Saleh,et al. Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton , 2010, Proceedings of the National Academy of Sciences.
[66] D. Chang,et al. Triggering of DC migration by dengue virus stimulation of COX‐2‐dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation , 2009, European journal of immunology.
[67] G. Klein,et al. Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein–Barr virus infection , 2009, Immunology.
[68] Robert J. Lefkowitz,et al. Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands , 2009, Proceedings of the National Academy of Sciences.
[69] E. Wherry,et al. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients. , 2009, Journal of hepatology.
[70] A. Coyle,et al. Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection. , 2009, The Journal of infectious diseases.
[71] S. Eo,et al. Genetic co‐transfer of CCR7 ligands enhances immunity and prolongs survival against virulent challenge of pseudorabies virus , 2009, Immunology and cell biology.
[72] A. Rothman,et al. Understanding the contribution of cellular immunity to dengue disease pathogenesis , 2008, Immunological reviews.
[73] M. Groettrup,et al. Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis , 2008, Journal of Cell Science.
[74] Antal Rot,et al. CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.
[75] J. Mora,et al. Differentiation and homing of IgA-secreting cells , 2008, Mucosal Immunology.
[76] Suha M. Saleh,et al. CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. , 2007, Blood.
[77] Peter H Seeberger,et al. Profiling heparin-chemokine interactions using synthetic tools. , 2007, ACS chemical biology.
[78] Jennifer L. Reed,et al. Severe Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyte Responses , 2007, The Journal of infectious diseases.
[79] Pedro Romero,et al. Four Functionally Distinct Populations of Human Effector-Memory CD8+ T Lymphocytes1 , 2007, The Journal of Immunology.
[80] T. Onodera,et al. Chemokines CCL19 and CCL21 promote activation-induced cell death of antigen-responding T cells. , 2007, Blood.
[81] A. Hartmann,et al. Cellular Target Genes of Epstein-Barr Virus Nuclear Antigen 2 , 2006, Journal of Virology.
[82] Graeme Milligan,et al. The chemokine receptor CCX‐CKR mediates effective scavenging of CCL19 in vitro , 2006, European journal of immunology.
[83] Guttorm Haraldsen,et al. Coy decoy with a new ploy: Interceptor controls the levels of homeostatic chemokines , 2006, European journal of immunology.
[84] J. Connolly,et al. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. , 2006, Blood.
[85] H. Blum,et al. Expression of the Interleukin-7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection , 2006, Journal of Virology.
[86] E. Kremmer,et al. A Somatic Knockout of CBF1 in a Human B-Cell Line Reveals that Induction of CD21 and CCR7 by EBNA-2 Is Strictly CBF1 Dependent and that Downregulation of Immunoglobulin M Is Partially CBF1 Independent , 2005, Journal of Virology.
[87] H. Schramek,et al. HIV-1-Induced Migration of Monocyte-Derived Dendritic Cells Is Associated with Differential Activation of MAPK Pathways1 , 2004, The Journal of Immunology.
[88] A. Thomson,et al. Migratory responses of murine hepatic myeloid, lymphoid-related, and plasmacytoid dendritic cells to CC chemokines. , 2004, Transplantation.
[89] A. Cuadrado,et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. , 2004, Blood.
[90] T. Blankenstein,et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. , 2004, Immunity.
[91] T. Wolff,et al. CC Chemokine Receptor 7 Expression by Effector/Memory CD4+ T Cells Depends on Antigen Specificity and Tissue Localization during Influenza A Virus Infection , 2004, Journal of Virology.
[92] T. Kohout,et al. Differential Desensitization, Receptor Phosphorylation, β-Arrestin Recruitment, and ERK1/2 Activation by the Two Endogenous Ligands for the CC Chemokine Receptor 7* , 2004, Journal of Biological Chemistry.
[93] U. V. von Andrian,et al. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.
[94] B. Rouse,et al. Codelivery of CCR7 Ligands as Molecular Adjuvants Enhances the Protective Immune Response against Herpes Simplex Virus Type 1 , 2003, Journal of Virology.
[95] B. Rouse,et al. Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity. , 2003, Virology.
[96] M. Lipp,et al. Shaping Up Adaptive Immunity: The Impact of CCR7 and CXCR5 on Lymphocyte Trafficking , 2003, Microcirculation.
[97] G. Pantaleo,et al. Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV‐1 and cytomegalovirus infections , 2002, European journal of immunology.
[98] Y. Yanagawa,et al. CCL19 induces rapid dendritic extension of murine dendritic cells. , 2002, Blood.
[99] D. Voehringer,et al. Cutting Edge: CCR7+ and CCR7− Memory T Cells Do Not Differ in Immediate Effector Cell Function1 , 2002, The Journal of Immunology.
[100] D. Richman,et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.
[101] M. Baggiolini,et al. The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC , 2001, European journal of immunology.
[102] S. Chensue. Molecular Machinations: Chemokine Signals in Host-Pathogen Interactions , 2001, Clinical Microbiology Reviews.
[103] R. A. Johnson,et al. The role of MKK1/2 kinase activity in human cytomegalovirus infection. , 2001, The Journal of general virology.
[104] P. Murphy. Viral exploitation and subversion of the immune system through chemokine mimicry , 2001, Nature Immunology.
[105] C. Murdoch,et al. Chemokine receptors and their role in inflammation and infectious diseases. , 2000, Blood.
[106] H. Pircher,et al. Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity , 1999, European journal of immunology.
[107] E. Wolf,et al. CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.
[108] J. Kim,et al. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. , 1999, Journal of immunology.
[109] O. Yoshie,et al. Secondary Lymphoid-tissue Chemokine Is a Functional Ligand for the CC Chemokine Receptor CCR7* , 1998, The Journal of Biological Chemistry.
[110] P. Doherty,et al. Effector CD4+ and CD8+ T‐cell mechanisms in the control of respiratory virus infections , 1997, Immunological reviews.
[111] M. Ridanpää,et al. Molecular Cloning of a Novel Human CC Chemokine Secondary Lymphoid-Tissue Chemokine That Is a Potent Chemoattractant for Lymphocytes and Mapped to Chromosome 9p13* , 1997, The Journal of Biological Chemistry.
[112] E. Kieff,et al. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.
[113] D. Legler,et al. CCR 7 Is Recruited to the Immunological Synapse , Acts as Co-stimulatory Molecule and Drives LFA-1 Clustering for Efficient T Cell Adhesion Through ZAP 70 , 2019 .
[114] R. Shattock,et al. Inhibition of HIV-1 infection of primary CD 4 + T-cells by gene editing of CCR 5 using adenovirus-delivered CRISPR / Cas 9 , 2015 .
[115] J. Benovic,et al. β-arrestins and G protein-coupled receptor trafficking. , 2014, Handbook of experimental pharmacology.
[116] B. Moser,et al. Chemokines , 2005, Immunologic research.
[117] B. Rouse,et al. Codelivery of CCR 7 Ligands as Molecular Adjuvants Enhances the Protective Immune Response against Herpes Simplex Virus Type 1 , 2003 .
[118] Antonio Alcami,et al. Viral mimicry of cytokines, chemokines and their receptors , 2003, Nature Reviews Immunology.
[119] Y. Yanagawa,et al. CCL 19 induces rapid dendritic extension of murine dendritic cells , 2002 .
[120] 外川 綱生,et al. 当院におけるMultiple Myeloma Cellsの表面形質の検討 , 2002 .
[121] E. Huang,et al. The role of MKK 1 / 2 kinase activity in human cytomegalovirus infection , 2022 .